Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Polymorphisms in dopaminergic system genes; association with criminal behavior and self-reported aggression in violent prison inmates from Pakistan.

Qadeer MI, Amar A, Mann JJ, Hasnain S.

PLoS One. 2017 Jun 5;12(6):e0173571. doi: 10.1371/journal.pone.0173571. eCollection 2017.

2.

Behavioral and Neural Manifestations of Reward Memory in Carriers of Low-Expressing versus High-Expressing Genetic Variants of the Dopamine D2 Receptor.

Richter A, Barman A, Wüstenberg T, Soch J, Schanze D, Deibele A, Behnisch G, Assmann A, Klein M, Zenker M, Seidenbecher C, Schott BH.

Front Psychol. 2017 May 1;8:654. doi: 10.3389/fpsyg.2017.00654. eCollection 2017.

3.

New Repeat Polymorphism in the AKT1 Gene Predicts Striatal Dopamine D2/D3 Receptor Availability and Stimulant-Induced Dopamine Release in the Healthy Human Brain.

Shumay E, Wiers CE, Shokri-Kojori E, Kim SW, Hodgkinson CA, Sun H, Tomasi D, Wong CT, Weinberger DR, Wang GJ, Fowler JS, Volkow ND.

J Neurosci. 2017 May 10;37(19):4982-4991. doi: 10.1523/JNEUROSCI.3155-16.2017. Epub 2017 Apr 17.

PMID:
28416594
4.

The impact of common dopamine D2 receptor gene polymorphisms on D2/3 receptor availability: C957T as a key determinant in putamen and ventral striatum.

Smith CT, Dang LC, Buckholtz JW, Tetreault AM, Cowan RL, Kessler RM, Zald DH.

Transl Psychiatry. 2017 Apr 11;7(4):e1091. doi: 10.1038/tp.2017.45.

5.

Imaging Genetics and Genomics in Psychiatry: A Critical Review of Progress and Potential.

Bogdan R, Salmeron BJ, Carey CE, Agrawal A, Calhoun VD, Garavan H, Hariri AR, Heinz A, Hill MN, Holmes A, Kalin NH, Goldman D.

Biol Psychiatry. 2017 Aug 1;82(3):165-175. doi: 10.1016/j.biopsych.2016.12.030. Epub 2017 Jan 13. Review.

PMID:
28283186
6.

Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status.

Eisenstein SA, Bogdan R, Love-Gregory L, Corral-Frías NS, Koller JM, Black KJ, Moerlein SM, Perlmutter JS, Barch DM, Hershey T.

Synapse. 2016 Oct;70(10):418-31. doi: 10.1002/syn.21916. Epub 2016 Jun 17.

7.

Food cravings, food addiction, and a dopamine-resistant (DRD2 A1) receptor polymorphism in Asian American college students.

Yeh J, Trang A, Henning SM, Wilhalme H, Carpenter C, Heber D, Li Z.

Asia Pac J Clin Nutr. 2016;25(2):424-9. doi: 10.6133/apjcn.102015.05.

8.
9.

Dopamine in socioecological and evolutionary perspectives: implications for psychiatric disorders.

Yamaguchi Y, Lee YA, Goto Y.

Front Neurosci. 2015 Jun 16;9:219. doi: 10.3389/fnins.2015.00219. eCollection 2015.

10.

Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity.

Val-Laillet D, Aarts E, Weber B, Ferrari M, Quaresima V, Stoeckel LE, Alonso-Alonso M, Audette M, Malbert CH, Stice E.

Neuroimage Clin. 2015 Mar 24;8:1-31. doi: 10.1016/j.nicl.2015.03.016. eCollection 2015. Review.

11.

Valenced action/inhibition learning in humans is modulated by a genetic variant linked to dopamine D2 receptor expression.

Richter A, Guitart-Masip M, Barman A, Libeau C, Behnisch G, Czerney S, Schanze D, Assmann A, Klein M, Düzel E, Zenker M, Seidenbecher CI, Schott BH.

Front Syst Neurosci. 2014 Aug 6;8:140. doi: 10.3389/fnsys.2014.00140. eCollection 2014. Erratum in: Front Syst Neurosci. 2015;9:36.

12.

Lack of association between DRD2 and OPRM1 genotypes and adiposity.

Hardman CA, Rogers PJ, Timpson NJ, Munafò MR.

Int J Obes (Lond). 2014 May;38(5):730-6. doi: 10.1038/ijo.2013.144. Epub 2013 Aug 6.

13.

Motivational salience and genetic variability of dopamine D2 receptor expression interact in the modulation of interference processing.

Richter A, Richter S, Barman A, Soch J, Klein M, Assmann A, Libeau C, Behnisch G, Wüstenberg T, Seidenbecher CI, Schott BH.

Front Hum Neurosci. 2013 Jun 5;7:250. doi: 10.3389/fnhum.2013.00250. eCollection 2013.

14.

The TaqIA RFLP is associated with attenuated intervention-induced body weight loss and increased carbohydrate intake in post-menopausal obese women.

Cameron JD, Riou MÈ, Tesson F, Goldfield GS, Rabasa-Lhoret R, Brochu M, Doucet É.

Appetite. 2013 Jan;60(1):111-116. doi: 10.1016/j.appet.2012.09.010. Epub 2012 Sep 29.

15.

Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction.

Jarcho JM, Mayer EA, Jiang ZK, Feier NA, London ED.

Pain. 2012 Apr;153(4):744-54. doi: 10.1016/j.pain.2012.01.002. Epub 2012 Mar 3. Review.

16.

Dopamine and binge eating behaviors.

Bello NT, Hajnal A.

Pharmacol Biochem Behav. 2010 Nov;97(1):25-33. doi: 10.1016/j.pbb.2010.04.016. Epub 2010 Apr 24. Review.

17.

Association between dopaminergic polymorphisms and borderline personality traits among at-risk young adults and psychiatric inpatients.

Nemoda Z, Lyons-Ruth K, Szekely A, Bertha E, Faludi G, Sasvari-Szekely M.

Behav Brain Funct. 2010 Jan 12;6:4. doi: 10.1186/1744-9081-6-4.

18.

Dopamine D2 receptor polymorphisms and susceptibility to alcohol dependence in Indian males: a preliminary study.

Prasad P, Ambekar A, Vaswani M.

BMC Med Genet. 2010 Feb 11;11:24. doi: 10.1186/1471-2350-11-24.

19.

Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

Haile CN, Kosten TR, Kosten TA.

Am J Drug Alcohol Abuse. 2009;35(3):161-77. doi: 10.1080/00952990902825447. Review.

20.

Genetic contributions to avoidance-based decisions: striatal D2 receptor polymorphisms.

Frank MJ, Hutchison K.

Neuroscience. 2009 Nov 24;164(1):131-40. doi: 10.1016/j.neuroscience.2009.04.048. Epub 2009 Apr 22.

Supplemental Content

Support Center